Elevated mean platelet volume is associated with impaired coronary microvascular function in patients with idiopathic dilated cardiomyopathy

References

• Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Yamaguchi H, Kakoi H, Takabatake Y. Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathy. Am Heart J. 1994; 127: 376–381
   PubMed Web of Science ®Google Scholar
• Erdogan D, Gullu H, Caliskan M, Ciftci O, Baycan S, Yildirir A, Muderrisoglu H. Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy. Heart. 2007; 93: 319–324
   PubMed Web of Science ®Google Scholar
• Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, Gallopin M, Salvadori P, Sorace O, Carpeggiani C, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation. 2002; 105: 186–193
   PubMedGoogle Scholar
• Erdogan D, Yildirim I, Ciftci O, Ozer I, Caliskan M, Gullu H, Muderrisoglu H. Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function. Circulation. 2007; 115: 593–599
   PubMed Web of Science ®Google Scholar
• Caiati C, Zedda N, Montaldo C, Montischi R, Iliceto S. Contrast-enhanced transthoracic second harmonic echo Doppler with adenosine: A noninvasive, rapid and effective method for coronary flow reserve assessment. J Am Coll Cardiol. 1999; 34: 122–130
   PubMed Web of Science ®Google Scholar
• Saraste M, Koskenvuo J, Knuuti J, Toikka J, Laine H, Niemi P, Sakuma H, Hartiala J. Coronary flow reserve: Measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin Physiol. 2001; 21: 114–122
   PubMedGoogle Scholar
• Lip GYH, Gibbs CR. Does heart failure confer a hypercoagulable state?. J Am Coll Cardiol. 1999; 33: 1424–1426
   PubMed Web of Science ®Google Scholar
• Chung I, Lip GYH. Platelets and heart failure. Eur Heart J. 2006; 27: 2623–2631
   PubMed Web of Science ®Google Scholar
• Jafri SM, Ozawz T, Mammen E, Levine TB, Johnson C, Goldstein S. Platelet function, thrombin and fibrinolytic activity in patients with heart failure. Eur Heart J. 1993; 14: 205–212
   PubMed Web of Science ®Google Scholar
• Erne P, Wardle J, Sanders K, Lewis SM, Maseri A. Mean platelet volume and size distribution and their sensitivity to agonists in patients with coronary artery disease and congestive heart failure. Thromb Haemost. 1988; 59: 259–263
   PubMedGoogle Scholar
• Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: Is there a practical index of platelet activity?. Clin Appl Thromb Hemost. 2003; 9: 177–190
   PubMed Web of Science ®Google Scholar
• Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: Methodological issues. Platelets. 2002; 13: 301–306
   PubMed Web of Science ®Google Scholar
• Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996; 7: 157–161
   PubMed Web of Science ®Google Scholar
• D'Erasmo E, Aliberti G, Celi FS, Romagnoli E, Vecci E, Mazzuoli GF. Platelet count, mean platelet volume and their relation to prognosis in cerebral infarction. J Intern Med. 1990; 227: 11–14
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006; 7: 79–108
   PubMed Web of Science ®Google Scholar
• Jagroop IA, Tsiara S, Mikhailidis DP. Mean platelet volume as an indicator of platelet activation: Methodological issues. Platelets. 2003; 14: 335–336
   PubMed Web of Science ®Google Scholar
• Kamath S, Blann AD, Lip GY. Platelet activation: Assessment and quantification. Eur Heart J. 2001; 22: 1561–1571
   PubMed Web of Science ®Google Scholar
• Karpatkin S, Khan Q, Freedman M. Heterogeneity of platelet function. Correlation with platelet volume. Am J Med. 1978; 64: 542–546
   PubMedGoogle Scholar
• Jakubowski JA, Adler B, Thompson CB, Valeri CR, Deykin D. Influence of platelet volume on the ability of prostacyclin to inhibit platelet aggregation and the release reaction. J Lab Clin Med. 1985; 105: 271–276
   PubMed Web of Science ®Google Scholar
• Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract. 2009; 63: 1509–1515
   PubMed Web of Science ®Google Scholar
• Serebruany V, McKenzie M, Meister A, Fuzaylov S, Gurbel P, Atar D, Gattis W, O’Connor C. Whole blood impedence aggregometry for the assessment of platelet function in patients with congestive heart failure (EPCOT Trial). Eur J Heart Fail. 2002; 4: 461–467
   PubMed Web of Science ®Google Scholar
• Serebruany VL, Murugesan SR, Pothula A, Atar D, Lowry DR, O’Connor CM, Gurbel PA. Increased soluble platelet/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy. Eur J Heart Fail. 1999; 1: 243–249
   Google Scholar
• Gurbel PA, Gattis WA, Fuzaylov SF, Gaulden L, Hasselblad V, Serebruany VL, O’Connor CM. Evaluation of platelets in heart failure: Is platelet severity related to etiology, functional class, or clinical outcomes?. Am Heart J. 2002; 143: 1068–1075
   PubMed Web of Science ®Google Scholar
• O’Connor CM, Gurbel PA, Serebruany VL. Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure. Am J Cardiol. 1999; 83: 1345–1349
   PubMed Web of Science ®Google Scholar
• Ueland T, Aukrust P, Yndestad A, Otterdal K, Froland SS, Dickstein K, Kjekshus J, Gullestad L, Damas JK. Soluble CD40 ligand in acute and chronic heart failure. Eur Heart J. 2005; 26: 1101–1107
   PubMed Web of Science ®Google Scholar
• Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Yamanaka T, Kakoi H, Takabatake Y. Coronary flow reserve in patients with dilated cardiomyopathy. Am Heart J. 1993; 125: 93–98
   PubMedGoogle Scholar
• van den Heuvel AF, van Veldhuisen DJ, van der Wall EE, Blanksma PK, Siebelink HM, Vaalburg WM, van Gilst WH, Crijns HJ. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2000; 35: 19–28
   PubMedGoogle Scholar
• Nitenberg A, Foult JM, Blanchet F, Zouioueche S. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy. Am J Cardiol. 1985; 55: 748–754
   PubMedGoogle Scholar
• Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990; 323: 27–36
   PubMed Web of Science ®Google Scholar
• Santagata P, Rigo F, Gherardi S, Pratali L, Drozdz J, Varga A, Picano E. Clinical and functional determinants of coronary flow reserve in non-ischemic dilated cardiomyopathy: An echocardiographic study. Int J Cardiol. 2005; 105: 46–52
   PubMedGoogle Scholar
• Tsagalou EP, Anastasiou-Nana M, Agapitos E, Gika A, Drakos SG, Terrovitis JV, Ntalianis A, Nanas JN. Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2008; 52: 1391–1398
   PubMedGoogle Scholar
• Sezer M, Okcular I, Goren T, Oflaz H, Nisanci Y, Umman B, Mercanoglu F, Bilge AK, Meric M, Umman S. Association of haematological indices with the degree of microvascular injury in patients with acute anterior wall myocardial infarction treated with primary percutaneous coronary intervention. Heart. 2007; 93: 313–318
   PubMedGoogle Scholar